Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tamoxifen, raloxifene, and the prevention of breast cancer.

× No keyword cloud information.

44 in total

1. Raloxifene as a multifunctional medicine? Current trials will show whether it is effective in both osteoporosis and breast cancer.

Authors: V C Jordan; M Morrow
Journal: BMJ Date: 1999-08-07

Review 2. Novel agents for chemoprevention, screening methods, and sampling issues.

Authors: Mary Jo Fackler; Ella Evron; Seema A Khan; Saraswati Sukumar
Journal: J Mammary Gland Biol Neoplasia Date: 2003-01 Impact factor: 2.673

3. The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.

Authors: Teshome B Gherezghiher; Bradley Michalsen; R Esala P Chandrasena; Zhihui Qin; Johann Sohn; Gregory R J Thatcher; Judy L Bolton
Journal: Chem Biol Interact Date: 2012-01-28 Impact factor: 5.192

Review 4. Bioactivation of Selective Estrogen Receptor Modulators (SERMs).

Authors: Tamara S Dowers; Zhi-Hui Qin; Gregory R J Thatcher; Judy L Bolton
Journal: Chem Res Toxicol Date: 2006-09 Impact factor: 3.739

Review 5. Challenges in the gynecologic care of premenopausal women with breast cancer.

Authors: Jamie N Bakkum-Gamez; Shannon K Laughlin; Jani R Jensen; Clement O Akogyeram; Sandhya Pruthi
Journal: Mayo Clin Proc Date: 2011-02-09 Impact factor: 7.616

6. Raloxifene and/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats.

Authors: Alicia A Walf; Cheryl Anne Frye
Journal: Behav Pharmacol Date: 2010-05 Impact factor: 2.293

7. Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.

Authors: Gaurav Bharadwaj; Patricia G Z Benini; Debashree Basudhar; Cyf N Ramos-Colon; Gail M Johnson; Marti M Larriva; Larry K Keefer; Daniela Andrei; Katrina M Miranda
Journal: Nitric Oxide Date: 2014-09-02 Impact factor: 4.427

8. The Transactivating Function 2 (AF-2) of Estrogen Receptor (ER) α is Indispensable for ERα-mediated Physiological Responses and AF-1 Activity.

Authors: Yukitomo Arao; Katherine J Hamilton; Kenneth S Korach
Journal: Open J Endocr Metab Dis Date: 2013-08-06

Review 9. Tracking progesterone receptor-mediated actions in breast cancer.

Authors: Todd P Knutson; Carol A Lange
Journal: Pharmacol Ther Date: 2013-11-26 Impact factor: 12.310

10. Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system.

Authors: D E Dluzen; J L McDermott; L I Anderson
Journal: Neurotox Res Date: 2001-07 Impact factor: 3.911